Formulation Strategies for Ezetimibe and Its Combinations: Advancing Biopharmaceutical and Therapeutic Potential

14. October 2025

Abstract Ezetimibe is a cholesterol absorption inhibitor widely used in the treatment of dyslipidemia. However, its clinical efficacy is limited...

CPHI Frankfurt 2025 – with a focus on excipients

1. October 2025

This year CPHI Europe opens its doors in Frankfurt at Messe Frankfurt. From 28th to 30th October you can have...

Schematic overview of therapeutic strategies using β-cyclodextrin for colon-targeted drug delivery.

β-cyclodextrin-based multifunctional carriers for colon-targeted drug delivery: advances in hydrogel systems and mucoadhesive strategies

17. August 2025

Oral drug delivery to the colon remains a formidable challenge due to the harsh conditions of the upper gastrointestinal tract,...

Spectroscopic and Structural Investigations of Quercetin/Sulfobutylether-β-Cyclodextrin Inclusion Complex Incorporated pH – responsive Electrospun Nanofibers for Colon – Specific Delivery

25. May 2025

Abstract The present study deals with development and characterization of quercetin (QCT) – loaded sulfobutylether-β-cyclodextrin (SBE-β-CD) inclusion complex (IC) incorporated...

An Experimental Design Approach for Producing Curcumin-Loaded Solid Lipid Nanoparticles

9. April 2025

Abstract Background/Objectives: Curcumin has well-established efficacy in a variety of disorders due to its prominent antioxidant, antiaging, anti-inflammatory, chemosensitizing, and...

Photo and video recap Pharma Excipients @CPHI Milan 2024

15. October 2024

This year´s CPHI Europe happend last week from 8th to 10th October in Milano at Fiera Milano. . Pharma Excipients...

CPHI Milan 2024 – with a focus on excipients

12. September 2024

This year CPHI Europe opens its doors in Milano at Fiera Milano. From 8th to 10th October you can have...

Fabrication of β-cyclodextrin and 2-hydroxypropyl-β-cyclodextrin inclusion complexes of Palbociclib: Physicochemical characterization, solubility enhancement, in -silico studies, in vitro assessment in MDA-MB-231 cell line

3. April 2024

Palbociclib (PAL) is an anti-cancer molecule that is highly selective for CDK4/6 inhibition and approved for the management of advanced...

Chitosan and Anionic Solubility Enhancer Sulfobutylether-β-Cyclodextrin-Based Nanoparticles as Dexamethasone Ophthalmic Delivery System for Anti-Inflammatory Therapy

1. March 2024

Abstract Cataract surgery interventions are constantly increasing, particularly among adult and elderly patients. This type of surgery can lead to...

Febuxostat ternary inclusion complex using SBE7-βCD in presence of a water-soluble polymer: physicochemical characterization, in vitro dissolution, and in vivo evaluation

19. January 2024

Febuxostat (FBX), a potent xanthine oxidase inhibitor, is widely used as a blood uric acid-reducing agent and has recently shown...

Captisol